Kobayashi’s Niranex is the flagship product of Kobayashi Pharmaceutical, and most of its revenue and profits are supported by this medicine.
If it is really beaten by Oracle Nova Dias, then Kobayashi Pharmaceutical’s vitality will definitely be greatly injured.
So someone asked Masayoshi Kobayashi: “Mr. Kobayashi, we can’t just wait and die like this! Do you have any good solutions?”
Kobayashi Masayoshi said: “There is also a way to deal with it, that is, we must increase investment in drug research and development, and we must quickly upgrade our current products. If our Niranex can surpass Oracle in terms of efficacy. Stomach, the market must still be ours!”
The person in charge of R&D opened the mouth and said: “My lord, if you want to increase investment in R&D, you need a huge budget. The company was sacked a lot of money some time ago. Can it still afford it now?”
RESTRICTED CONTENT
Sorry, this chapter is locked. Only readers with active membership account can access this page.
Visit https://virtual-novel.net/donate/ to have active membership account.
Alternative site is available for free readers (no regular updates for some titles)
OR LOGIN: